Preoperative intravitreal injection of ranibizumab for patients with severe proliferative diabetic retinopathy contributes to a decreased risk of postoperative neovascular glaucoma

Acta Ophthalmol. 2016 Jun;94(4):414-5. doi: 10.1111/aos.13019. Epub 2016 Mar 24.

Authors

Qianyi Lu¹, Chen Zou¹, Hui Cao¹, Minjie Zhao¹, Siqing Yu¹, Qinghua Qiu¹, Xun Xu¹, Zhi Zheng¹

Affiliation

¹ Department of Ophthalmology, First People's Hospital of Shanghai, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

PMID: 27010230
DOI: 10.1111/aos.13019

No abstract available

Publication types

Letter

MeSH terms

Aged
Angiogenesis Inhibitors / therapeutic use*
Diabetic Retinopathy / drug therapy*
Diabetic Retinopathy / physiopathology
Female
Glaucoma, Neovascular / prevention & control*
Humans
Intravitreal Injections
Male
Middle Aged
Postoperative Complications / prevention & control*
Ranibizumab / therapeutic use*
Retrospective Studies
Vascular Endothelial Growth Factor A / antagonists & inhibitors
Visual Acuity / physiology
Vitrectomy

Substances

Angiogenesis Inhibitors
VEGFA protein, human
Vascular Endothelial Growth Factor A
Ranibizumab